Literature DB >> 8327187

Neurofibrillary tangle densities in the hippocampal formation in a non-demented population define subgroups of patients with differential early pathologic changes.

C Bouras1, P R Hof, J H Morrison.   

Abstract

Detailed analyses of the neuropathologic changes in the cerebral cortex of elderly individuals and Alzheimer's disease patients have demonstrated that certain components of the neocortical and hippocampal circuits are likely to be selectively vulnerable. In order to investigate the distribution of lesions associated with aging as well as with the earliest symptoms of Alzheimer's disease, we performed a quantitative neuropathological evaluation of sixty-one non-demented patients from a geriatric hospital. All of the cases had neurofibrillary tangles in layer II of the entorhinal cortex, and many cases had an involvement of the CA1 field of the hippocampus and the inferior temporal cortex. In all of the cases, amyloid deposition was not correlated with age or with the number of neurofibrillary tangles. In addition, eight cases showed much higher neurofibrillary tangle counts than the remainder of the cases. It is proposed that these cases may represent the neuropathological correlate of the earliest stage of Alzheimer's disease that could antedate the appearance of clinical signs of cognitive decline and memory impairment.

Entities:  

Mesh:

Year:  1993        PMID: 8327187     DOI: 10.1016/0304-3940(93)90305-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  28 in total

1.  Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease.

Authors:  T Gómez-Isla; J L Price; D W McKeel; J C Morris; J H Growdon; B T Hyman
Journal:  J Neurosci       Date:  1996-07-15       Impact factor: 6.167

2.  Cognitive decline associated with pathological burden in primary age-related tauopathy.

Authors:  Kyra S Jefferson-George; David A Wolk; Edward B Lee; Corey T McMillan
Journal:  Alzheimers Dement       Date:  2017-03-16       Impact factor: 21.566

Review 3.  Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2011-02       Impact factor: 3.911

4.  Senile plaques do not progressively accumulate with normal aging.

Authors:  I R Mackenzie
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: retrospective clinicopathological evaluation of a 10-year autopsy population.

Authors:  P Giannakopoulos; P R Hof; S Mottier; J P Michel; C Bouras
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 6.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

7.  Neurofibrillary tangle predominant form of senile dementia of Alzheimer type: a rare subtype in very old subjects.

Authors:  C Bancher; K A Jellinger
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 8.  Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Continuum (Minneap Minn)       Date:  2019-02

9.  Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: evidence for general cortical involvement.

Authors:  P Vermersch; Y Robitaille; L Bernier; A Wattez; D Gauvreau; A Delacourte
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

10.  Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.

Authors:  V Buée-Scherrer; L Buée; P R Hof; B Leveugle; C Gilles; A J Loerzel; D P Perl; A Delacourte
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.